MP35-15 PAIN CATASTROPHIZING IS ASSOCIATED WITH STENT-RELATED PAIN AFTER URETEROSCOPIC LASER LITHOTRIPSY

Abstract

You have accessJournal of UrologyCME1 Apr 2023MP35-15 PAIN CATASTROPHIZING IS ASSOCIATED WITH STENT-RELATED PAIN AFTER URETEROSCOPIC LASER LITHOTRIPSY Alan J. Yaghoubian, Sarah Mozafarpour, Roman Shimonov, Raymond Khargi, Blair Gallante, Dara Lundon, Johnathan A. Khusid, William M. Atallah, and Mantu Gupta Alan J. YaghoubianAlan J. Yaghoubian More articles by this author , Sarah MozafarpourSarah Mozafarpour More articles by this author , Roman ShimonovRoman Shimonov More articles by this author , Raymond KhargiRaymond Khargi More articles by this author , Blair GallanteBlair Gallante More articles by this author , Dara LundonDara Lundon More articles by this author , Johnathan A. KhusidJohnathan A. Khusid More articles by this author , William M. AtallahWilliam M. Atallah More articles by this author , and Mantu GuptaMantu Gupta More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000003269.15AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Ureteral stent-related pain varies in intensity for different patients. While stent-specific factors (e.g. stent position) may influence symptoms, patient-specific factors remain elusive. The pain catastrophizing scale (PCS) is a validated questionnaire quantifying the degree to which an individual may catastrophize painful stimuli. We aim to determine whether PCS score is associated with stent symptoms after ureteroscopic laser lithotripsy (URSLL). METHODS: This is an ongoing prospective study of patients undergoing URSLL. All patients completed the PCS prior to undergoing URSLL with stent placement and were labeled as catastrophizers (top third), non-catastrophizers (bottom third), or semi-catastrophizers (middle third). The ureteral stent symptom questionnaire (USSQ) was completed at 2 time points: post-op day (POD)#1 and POD#10. Prescriptions for phenazopyridine, ibuprofen, and oxybutynin were given. Outcomes included USSQ scores, total analgesic pills taken, pain-related office phone calls, and need for narcotic prescriptions. RESULTS: In sum 41 patients have been enrolled. Median USSQ pain scores on POD#10 were significantly higher among catastrophizers as compared to non-catastrophizers (24.5 vs. 14.0, p=0.036). There were no differences between all 3 groups in other USSQ domains. Catastrophizers took more tablets of phenazopyridine (11.0 vs. 5.5, p=0.027) and total prescribed tablets (26.5 vs. 15.5, p=0.023) compared to non-catastrophizers. Differences between number of pain-related calls between catastrophizers and non-catastrophizers approached significance (46.2% vs. 0%, p=0.057). Semi-catastrophizers had no significantly different outcomes from the other two groups. CONCLUSIONS: Pain catastrophizers have higher post-URSLL pain index scores, use more pain medications, and likely call the office more frequently. The PCS may ultimately become a practical tool to personalize patient care by identifying those at highest risk for severe stent pain. Source of Funding: None © 2023 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 209Issue Supplement 4April 2023Page: e475 Advertisement Copyright & Permissions© 2023 by American Urological Association Education and Research, Inc.MetricsAuthor Information Alan J. Yaghoubian More articles by this author Sarah Mozafarpour More articles by this author Roman Shimonov More articles by this author Raymond Khargi More articles by this author Blair Gallante More articles by this author Dara Lundon More articles by this author Johnathan A. Khusid More articles by this author William M. Atallah More articles by this author Mantu Gupta More articles by this author Expand All Advertisement PDF downloadLoading ...